This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.94% per year. These returns cover a period from January 1, 1988 through June 1, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
insurance: Archive
Centene Stock Soars 66% YTD: Should Investors Chase the Rally?
by Kaibalya Pravo Dey
CNC stock's 66% rally reflects improving margins, stronger cash flow and renewed earnings growth, but can the turnaround keep gaining momentum?
CNCPositive Net Change UNHNegative Net Change ELVPositive Net Change
healthcare hmo insurance medical
EG Outperforms Industry, Trades Near 52-Week High: Time to Exit?
by Zacks Equity Research
Everest Group's disciplined underwriting, specialty business growth, investment income and capital management support long-term growth, though catastrophe and geopolitical risks remain.
EGNegative Net Change AEGPositive Net Change AIGNegative Net Change AIZNegative Net Change
insurance
MFC Outperforms Industry, Hits 52-Week High: How to Play the Stock
by Zacks Equity Research
Manulife Financial stock rallies on the back of a solid Asia business, an expanding Wealth and Asset Management business and a strong capital position.
MFCPositive Net Change RGANegative Net Change PRINegative Net Change SLFPositive Net Change
insurance
Accelerant Advances Fee-Based Model With WoodStar Partnership
by Zacks Equity Research
ARX partners with WoodStar to add $220M+ in underwriting capacity, advancing its fee-based model and expanding insurance growth opportunities.
ARXNegative Net Change CNONegative Net Change HMNNegative Net Change OWLPositive Net Change
finance insurance
RLI Trading at a Premium to Industry: How Should You Play the Stock?
by Zacks Equity Research
RLI's product diversification, underwriting discipline and shareholder-friendly capital strategy support long-term profitability and growth.
RLINegative Net Change TRVNegative Net Change WRBNegative Net Change CINFNegative Net Change
insurance
Can Progressive Surpass Estimates This Earnings Season?
by Zacks Equity Research
Progressive enters Q2 earnings season with higher premiums and investment income poised to offset rising costs, and a projected year-over-year profit decline.
PGRNegative Net Change TRVNegative Net Change CBNegative Net Change ACGLNegative Net Change
earnings insurance
Will Health Benefits Weakness Drag Elevance's Q2 Earnings?
by Zacks Equity Research
ELV faces Q2 pressure as weaker Health Benefits results and higher benefit expenses may weigh on earnings ahead of its July 15 report.
ELVPositive Net Change CAHNegative Net Change ALCNegative Net Change PMNPositive Net Change
earnings insurance medical
Is UNH Stock Worth Buying Ahead of Q2 Earnings? Key Estimates to Watch
by Kaibalya Pravo Dey
UnitedHealth faces Q2 pressure from membership declines, but medical cost management and long-term growth initiatives keep investors focused on July 16 results.
UNHNegative Net Change HUMPositive Net Change MOHNegative Net Change
earnings-outlook earnings-preview healthcare hmo insurance
Can AMSF Sustain Growth Despite a Tough Workers' Compensation Market?
by Piyali Saha Sikdar
AMERISAFE is growing premiums and maintaining underwriting profits despite pricing pressure, but can its disciplined strategy keep delivering shareholder value?
AMSFNegative Net Change HIGNegative Net Change EIGNegative Net Change
finance insurance
Humana Eyes 3% Medicare Advantage Margin: Can It Deliver?
by Piyali Saha Sikdar
Humana targets a 3% Medicare Advantage margin by 2028 while pursuing 25% 2026 membership growth and rebuilding profitability despite industry headwinds.
HUMPositive Net Change UNHNegative Net Change CVSPositive Net Change
insurance medical